Cargando…

Scientific Rationale for the Treatment of Cognitive Deficits from Long COVID

Sustained cognitive deficits are a common and debilitating feature of “long COVID”, but currently there are no FDA-approved treatments. The cognitive functions of the dorsolateral prefrontal cortex (dlPFC) are the most consistently afflicted by long COVID, including deficits in working memory, motiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fesharaki Zadeh, Arman, Arnsten, Amy F. T., Wang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303664/ https://www.ncbi.nlm.nih.gov/pubmed/37368329 http://dx.doi.org/10.3390/neurolint15020045

Ejemplares similares

Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19”
por: Fesharaki-Zadeh, Arman, et al.
Publicado: (2023)

Scientific rationale for the use of α2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders
por: Arnsten, Amy F. T., et al.
Publicado: (2023)

Oxidative Stress in Traumatic Brain Injury
por: Fesharaki-Zadeh, Arman
Publicado: (2022)

A rationale and model for addressing tobacco dependence in substance abuse treatment
por: Richter, Kimber P, et al.
Publicado: (2006)

Chronic Traumatic Encephalopathy: A Brief Overview
por: Fesharaki-Zadeh, Arman
Publicado: (2019)

A Case of Possible Chronic Traumatic Encephalopathy and Alzheimer’s Disease in an Ex-Football Player
por: Fesharaki-Zadeh, Arman
Publicado: (2021)

Loss of Prefrontal Cortical Higher Cognition with Uncontrollable Stress: Molecular Mechanisms, Changes with Age, and Relevance to Treatment
por: Datta, Dibyadeep, et al.
Publicado: (2019)

Increased Behavioral Deficits and Inflammation in a Mouse Model of Co-Morbid Traumatic Brain Injury and Post-Traumatic Stress Disorder
por: Fesharaki-Zadeh, Arman, et al.
Publicado: (2020)

Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
por: van Haren, Frank M. P., et al.
Publicado: (2020)

“MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
por: Kory, Pierre, et al.
Publicado: (2022)

Neuromodulation of prefrontal cortex cognitive function in primates: the powerful roles of monoamines and acetylcholine
por: Cools, Roshan, et al.
Publicado: (2021)

Guanfacine for the Treatment of Cognitive Disorders: A Century of Discoveries at Yale
por: Arnsten, Amy F.T., et al.
Publicado: (2012)

Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder
por: Arnsten, Amy FT, et al.
Publicado: (2005)

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA
por: Cohen, Joshua S, et al.
Publicado: (2016)

The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option
por: Bjermer, Leif, et al.
Publicado: (2019)

Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence
por: Fioravanti, Mario, et al.
Publicado: (2012)

Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
por: Kleanthous, Harry, et al.
Publicado: (2021)

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale
por: Berry, Colin, et al.
Publicado: (2016)

Scientific rationale of Indian AYUSH Ministry advisory for COVID-19 prevention, prophylaxis, and immunomodulation
por: Gupta, Prashant Kumar, et al.
Publicado: (2021)

Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence
por: Ignatowski, Tracey A., et al.
Publicado: (2014)

Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate
por: van Dyck, Christopher H., et al.
Publicado: (2020)

Ibrutinib combinations in CLL therapy: scientific rationale and clinical results
por: Timofeeva, Natalia, et al.
Publicado: (2021)

Vascular Dysfunctions Contribute to the Long-Term Cognitive Deficits Following COVID-19
por: Shabani, Zahra, et al.
Publicado: (2023)

Scientific Evidence and Rationale for the Development of Curcumin and Resveratrol as Nutraceutricals for Joint Health
por: Mobasheri, Ali, et al.
Publicado: (2012)

Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments
por: Martínez, Antón L., et al.
Publicado: (2021)

Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical Development
por: Davies, Andrew, et al.
Publicado: (2017)

Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B
por: Aguilar, Julio Cesar, et al.
Publicado: (2022)

Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence
por: Hach, Thomas, et al.
Publicado: (2023)

Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
por: Barrett, Christopher D., et al.
Publicado: (2020)

The genie in the bottle-magnified calcium signaling in dorsolateral prefrontal cortex
por: Arnsten, Amy F. T., et al.
Publicado: (2020)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
por: Janson, Christer, et al.
Publicado: (2017)

Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

Scientific rationale for a higher dose of nusinersen
por: Finkel, Richard S., et al.
Publicado: (2022)

Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics
por: Litwin, Alain H, et al.
Publicado: (2011)

PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging
por: Toyonaga, Takuya, et al.
Publicado: (2022)

Scientific Rationale for the Use of Alpha-Adrenergic Agonists and Glucocorticoids in the Therapy of Pediatric Stridor
por: Nino, Gustavo, et al.
Publicado: (2011)

Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale
por: Beitia, Maider, et al.
Publicado: (2021)

Chronic stimulation of alpha-2A-adrenoceptors with guanfacine protects rodent prefrontal cortex dendritic spines and cognition from the effects of chronic stress
por: Hains, Avis Brennan, et al.
Publicado: (2015)

PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers
por: Lee, Elizabeth K., et al.
Publicado: (2020)

The rationale for the treatment of long-Covid symptoms – A cardiologist's view
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8nr5seu4jrkvdks2ur1qhe05vv